Aura Biosciences Statistics
Total Valuation
AURA has a market cap or net worth of $291.81 million. The enterprise value is $157.22 million.
Important Dates
The last earnings date was Monday, March 24, 2025, after market close.
Earnings Date | Mar 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AURA has 50.23 million shares outstanding. The number of shares has increased by 25.32% in one year.
Current Share Class | 50.23M |
Shares Outstanding | 50.23M |
Shares Change (YoY) | +25.32% |
Shares Change (QoQ) | +0.55% |
Owned by Insiders (%) | 1.66% |
Owned by Institutions (%) | 47.58% |
Float | 32.01M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.09 |
P/TBV Ratio | 1.91 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.77, with a Debt / Equity ratio of 0.12.
Current Ratio | 10.77 |
Quick Ratio | 10.13 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -46.01% and return on invested capital (ROIC) is -28.87%.
Return on Equity (ROE) | -46.01% |
Return on Assets (ROA) | -27.46% |
Return on Invested Capital (ROIC) | -28.87% |
Return on Capital Employed (ROCE) | -57.35% |
Revenue Per Employee | n/a |
Profits Per Employee | -$976,618 |
Employee Count | 89 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, AURA has paid $112,000 in taxes.
Income Tax | 112,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.48% in the last 52 weeks. The beta is 0.30, so AURA's price volatility has been lower than the market average.
Beta (5Y) | 0.30 |
52-Week Price Change | -25.48% |
50-Day Moving Average | 7.50 |
200-Day Moving Average | 8.46 |
Relative Strength Index (RSI) | 29.80 |
Average Volume (20 Days) | 380,089 |
Short Selling Information
The latest short interest is 1.19 million, so 2.38% of the outstanding shares have been sold short.
Short Interest | 1.19M |
Short Previous Month | 1.12M |
Short % of Shares Out | 2.38% |
Short % of Float | 3.73% |
Short Ratio (days to cover) | 7.20 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -96.12M |
Pretax Income | -80.50M |
Net Income | -86.92M |
EBITDA | -94.89M |
EBIT | -96.12M |
Earnings Per Share (EPS) | -$1.75 |
Full Income Statement Balance Sheet
The company has $151.09 million in cash and $18.77 million in debt, giving a net cash position of $132.33 million or $2.63 per share.
Cash & Cash Equivalents | 151.09M |
Total Debt | 18.77M |
Net Cash | 132.33M |
Net Cash Per Share | $2.63 |
Equity (Book Value) | 151.97M |
Book Value Per Share | 3.04 |
Working Capital | 145.71M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$79.81 million and capital expenditures -$1.25 million, giving a free cash flow of -$81.06 million.
Operating Cash Flow | -79.81M |
Capital Expenditures | -1.25M |
Free Cash Flow | -81.06M |
FCF Per Share | -$1.61 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |